TFA Therapeutics (RAJAF) Current Assets (2020 - 2025)

TFA Therapeutics has reported Current Assets for 6 years, with the latest figure at $997742.0 in Q4 2025.

• On a quarterly basis, Current Assets rose 65.85% year-over-year to $997742.0 in Q4 2025; TTM through Dec 2025 was $997742.0, a 65.85% increase from a year earlier, with the FY2025 full-year figure at $997742.0, up 65.85% from the prior year.
• Current Assets was $997742.0 for Q4 2025 at TFA Therapeutics, up from $601602.0 in the prior quarter.
• The five-year high for Current Assets was $1.1 million in Q4 2021, with the low at $52135.0 in Q3 2023.
• Average Current Assets over 5 years is $601839.0, with a median of $551577.0 recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Current Assets tumbled 55.65% in 2022, then soared 83.88% in 2024.
• Over 5 years, Current Assets stood at $1.1 million in 2021, then sank by 55.65% to $501552.0 in 2022, then tumbled by 34.77% to $327175.0 in 2023, then surged by 83.88% to $601602.0 in 2024, then jumped by 65.85% to $997742.0 in 2025.
• The last three Current Assets figures came in at $997742.0 (Q4 2025), $601602.0 (Q4 2024), and $327175.0 (Q4 2023), per Business Quant data.